Related Experiment Video
Updated: May 15, 2026
09:05
Pooled CRISPR-Based Genetic Screens in Mammalian Cells
Published on: September 4, 2019
ATARiS: computational quantification of gene suppression phenotypes from multisample RNAi screens
Diane D Shao1, Aviad Tsherniak, Shuba Gopal
1Broad Institute of Harvard and MIT, Cambridge, Massachusetts 02142, USA.
Genome Research
|December 28, 2012
Summary
Researchers developed a new computational method, ATARiS, to improve the accuracy of RNA interference (RNAi) screens. This method helps identify gene targets by analyzing patterns across multiple samples, revealing HNF1B as a key oncogene in cancer cell survival.
Area of Science:
- Genomics
- Molecular Biology
- Bioinformatics
Background:
- Genome-scale RNA interference (RNAi) libraries are crucial for systematic gene function studies.
- Interpreting RNAi screens is challenging due to variable on-target and off-target effects of RNAi reagents.
Purpose of the Study:
- To develop a computational method for enhancing the reliability of RNAi screening data.
- To provide a robust approach for analyzing gene function through RNAi screens.
Main Methods:
- Introduced Analytic Technique for Assessment of RNAi by Similarity (ATARiS), a computational method.
- ATARiS leverages patterns across multiple samples to identify RNAi reagents targeting intended genes.
- Summarizes reagent effects to generate quantitative, gene-level phenotype values.
Main Results:
- ATARiS is effective with as few as 10 samples and applicable to large-scale screens.
- Applied ATARiS to RNAi data from over 100 human cancer cell lines.
- Identified HNF1B as a transforming oncogene essential for the survival of cancer cells with HNF1B amplifications.
Conclusions:
- ATARiS enhances the accuracy and interpretability of RNAi screening data.
- The method facilitates the identification of critical genes, such as HNF1B, in cancer biology.
- ATARiS is a valuable tool for gene function analysis in various biological contexts.
More Related Videos
Related Concept Videos
02:46Genetic Screens
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
02:15Experimental RNAi
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
03:21RNA-seq
RNA sequencing, or RNA-Seq, is a high-throughput sequencing technology used to study the transcriptome of a cell. Transcriptomics helps to interpret the functional elements of a genome and identify the molecular constituents of an organism. Additionally, it also helps in understanding the development of an organism and the occurrence of diseases.
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while microarray-based...
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while microarray-based...